Linking Immune Reconstitution to Cidofovir Treatment Duration and Viral Clearance in Pediatric HSCT Recipients.

Key Points

• Viral clearance is positively associated with immune reconstitution in pediatric HSCT recipients.
• Key evidence shows that treatment duration of cidofovir impacts both reconstitution and clearance rates.
• Analysis involves pediatric HSCT records over multiple treatment cycles, assessing immune recovery related to antiviral therapy.
• The findings may enable better management strategies for cidofovir treatment in pediatric patients post-HSCT.